Blue Horseshoe Stocks: Options Review & More

OPTIONS REVIEW

We had two fresh options trading ideas included in yesterday morning premarket report, and it should come as no shock to anyone who has been following our recent activity that we hit the nail on the head with both of them! We signaled some YELP and ROKU Calls, and of the eight sets of contracts we targeted, EIGHT produced big-time, multi-bag, single session gains!

YELP Weekly $43-44.50 Calls

$43 Calls – Range: 1.70-6.46 – Max Gain:  280%
$43.50 Calls – Range: 1.34-5.85 – Max Gain: 337%
$44 Calls – Range: 1.04-5.60 – Max Gain: 438%
$44.50 Calls – Range: .66-5.07 – Max Gain: 668%
________

ROKU Weekly $52-53.50 Calls

$52 Calls– Range: 2.00-5.85 – Max Gain:  193%
$52.50 Calls – Range: 1.50-5.35 – Max Gain: 257%
$53 Calls – Range: 1.36-4.80 – Max Gain: 253%
$53.50 Calls – Range: 1.10-4.40 – Max Gain: 300%
________

Fresh Idea:
OSTK Weekly $44.50-46.50


Extended Watchlist:
SA, IZEA, AWX, PLNT

Blue Horseshoe Stocks: Z Follow-Up & More

Zillow Group, Inc. Z

First thing’s first- we wanted to update our readers once again on the Zillow calls we made on Tuesday morning. We designated the Z Weekly $48-49 Calls as our targets and after a good first day, the stock continued its upward climb during yesterday’s session.

That move alloted for even further increases on our observed range of contracts, and pushed our two-day observed swings well into multi-bag territory:

$48 Calls – Range: 1.30-3.55 – Max Gain: 173%
$48.50 Calls – Range: 1.10-2.60 – Max Gain: 136%
$49 Calls – Range: .80-2.60 – Max Gain: 225%
________

Fresh Ideas:
YELP Weekly $43-44.50 Calls
ROKU Weekly $52-53.50 Calls


Healthmed Services, Inc HEME

It isn’t often these days that we target a subpenny OTC stock. Our long-time followers know that those were our primary focus when we started out exactly 7 years ago this past Tuesday. We did very well in that capacity for many years, despite having recently shifted focus more to fast-paced options trading.

Of any of the sectors we ever covered in the OTC space, cannabis has certainly been the most exciting, and continues to be one of our primary interests on the stock side of things to this day.

That’s why we just want to put HEME on our readers radars. Despite being listed as defunct on OTC Markets, the company recently revealed its intentions to get things back on track and enter the marijuana space.

According to its updated website, HEME is presently acquiring, leasing and licensing growers for the cultivation, production and distribution of cannabis and cannabis-related products in southern California. The project site has state Highway access, water and local transportation are convenient and accessible, and the City government has designated the project site – legal planting zoning.

We are going to keep tabs on the company’s progress toward not only developing in this new direction, but also coming current on its reporting.


Extended Watchlist:
WIN, UPL, TIVO, ANGI, CVNA, RDHL,

Blue Horseshoe Stocks: AAPL Recap & More

Apple, Inc. AAPL – Options Followup

Only seven trading days have elapsed since we slated some longer-term Apple options ideas for observation on the 1st of this month. We were looking at the AAPL 06/01 $167.50 & $170 Calls and we’re pleased to return just over a week later to report that AAPL has mounted a heck of a seven day upswing, facilitating some fantastic gains in our flagged contracts.

So far the $167.50′s have traded in a range from 4.36-19.98, an increase of 358%, while the $170′s exploded 435% from 3.30 to 17.64.



Trip Advisor, Inc. TRIP Weekly $45.50 & $46 Calls

We also had some fresh options ideas in yesterday’s morning report, the TRIP Weekly $45.50 & $46 Calls. What we got from those, was a highly respectable intraday performance.

The $45.50 Calls surged up from .85-2.30 for a single-session rip of 170%, and the $46′s ran from 1.35-2.77, a 105% pop.



Helios & Matheson Analytics, Inc. HMNY

We want to place HMNY on intensive bottom watch this morning after noticing the setup on the chart. The stock has been absolutely punished over the past couple of trading days, and as you can see below, the RSI is now in heavily oversold territory.

The last time the stock was this oversold, at the beginning of April, it recorded an upswing of over 100% so we’ll want to keep an eye on its activities. at least for the remainder of the week, and possibly longer.


More Fresh Options Ideas:
ROKU Weekly $38-40 Calls
FARO 05/18 $50 & $55 Calls


Extended Watchlist:
AGS, CVNA, TVTV, MYSZ, VSLR, SSOL, RGSE, HMIX, EBIO, RUN

Blue Horseshoe Stocks: GERN Recap & More

Geron Corp. GERN – Recap
It’s all well and good to seek out stocks that are set to make a big jump overnight, but slower growth plays also interest us greatly. GERN is an example of a stock that we tagged near the beginning of last month (02.05) which has performed well over an extended period of several weeks.

Subsequent to our tag of GERN, the stock saw a low of 2.025, and in a series of small, incremental daily gains, it steadily made its way up to a high of 4.47 yesterday, representing an increase of 121%. That’s a very respectable gain in roughly a six week period.


Wheeler Real Estate Investment Trust, Inc. WHLR

We want to take this opportunity to place WHLR on watch as a potential bottom-play. The stock has been greatly abused over the past several months, falling well below all its moving averages, and reaching egregiously oversold territory. There is also a fairly large gap on chart to the upside, something for which we routinely look.

We’ll keep an eye on WHLR in sessions to come looking for the confirmation of a bounce. It certainly has plenty of room to run when that occurs, so keep a sharp eye out.


Extended Watchlist:
LDSR, RJDG, RSII, RNVA, ROKU, DRRX, FNJN

Blue Horseshoe Stocks: NFLX Options & More

Sorrento Therapeutics, Inc. SRNE

Recently we’ve been delving back into our reports from late 2017, to review the ones that have made notable moves, and next up on the list SRNE.

We last signaled our interest in this as a bottom-watch play back on November 16th, and while it took a couple weeks for it to get out of its sideways-trading funk, the beginning of December brought the start of a fantastic run from an ultimate low of 2.15 that has persisted into the present. Yesterday the stock reached a new annual high of 8.05 (highest PPS since October ’16), marking an increase of 274%

This most recent push in what has definitely been a steady but sharp rise of the past six weeks may have been helped along by Celgene’s (CELG) buyout of Juno Therapeutics (JUNO), which share a market space with SRNE. The company also has some promising treatments in its pipeline.

Volume has recently been ramping up in a big way, too, so we’ll definitely continue to have an eye on this stock’s activity.


Netflix, Inc. NFLX – Options Idea

We’re always looking for a good opportunity to make some quick gains in the wake of a big company’s earnings, and NFLX is one that we’ve had quite a bit of experience with in that arena.

That’s why we’re going to enter an idea into the log this morning in the NFLX Weekly $247.50-255 Calls as the company posted a promising report including the addition of more than eight million new subscribers even despite its recent price increases.

Shares of NFLX broke a double top and are in blue skies, hitting a new all time high, so we’re very interested to track the ideas we’ve identified. They may be able to furnish us with some impressive gains.


Extended Watchlist:
CNET, ROKU, FATE, RMD, FNJN, VYGR